Sanjeev Kumar V. Vernekar

677 citations

16 papers · 577 indexed · h-index 13

Co-authors: Zhengqiang Wang Jayakanth Kankanala Michael A. Parniak Stefan G. Sarafianos Karen A. Kirby Venkata Ramana Sirivolu Li Qiu Robert J. Geraghty
Topics: HIV/AIDS drug development and treatment (11 papers)HIV Research and Treatment (10 papers)Hepatitis C virus research (4 papers)
Cited by: Virology Infectious Diseases Organic Chemistry
Journals: Journal of Medicinal Chemistry European Journal of Medicinal Chemistry Bioorganic & Medicinal Chemistry Letters
Partner nations: United States United Kingdom Switzerland

In The Last Decade

Sanjeev Kumar V. Vernekar

16 papers receiving 573 citations

Peers

Countries citing papers authored by Sanjeev Kumar V. Vernekar

Since Specialization

Citations

This map shows the geographic impact of Sanjeev Kumar V. Vernekar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanjeev Kumar V. Vernekar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanjeev Kumar V. Vernekar more than expected).

Fields of papers citing papers by Sanjeev Kumar V. Vernekar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanjeev Kumar V. Vernekar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanjeev Kumar V. Vernekar. The network helps show where Sanjeev Kumar V. Vernekar may publish in the future.

Co-authorship network of co-authors of Sanjeev Kumar V. Vernekar

This figure shows the co-authorship network connecting the top 25 collaborators of Sanjeev Kumar V. Vernekar. A scholar is included among the top collaborators of Sanjeev Kumar V. Vernekar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanjeev Kumar V. Vernekar. Sanjeev Kumar V. Vernekar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Design, Synthesis and Characterization of HIV-1 CA-Targeting Small Molecules: Conformational Restriction of PF74 2021 ·Viruses ·Rajkumar Lalji Sahani,(unknown),Sanjeev Kumar V. Vernekar,Lei Wang,Haijuan Du,Huanchun Zhang,(unknown),Mary C. Casey,Karen A. Kirby,Philip R. Tedbury,Jiashu Xie,Stefan G. Sarafianos,Zhengqiang Wang	12
2	Novel HIV-1 capsid-targeting small molecules of the PF74 binding site 2020 ·European Journal of Medicinal Chemistry ·Lei Wang,Mary C. Casey,Sanjeev Kumar V. Vernekar,Rajkumar Lalji Sahani,Jayakanth Kankanala,Karen A. Kirby,Haijuan Du,Atsuko Hachiya,Huanchun Zhang,Philip R. Tedbury,Jiashu Xie,Stefan G. Sarafianos,Zhengqiang Wang	19
3	Chemical profiling of HIV-1 capsid-targeting antiviral PF74 2020 ·European Journal of Medicinal Chemistry ·Lei Wang,Mary C. Casey,Sanjeev Kumar V. Vernekar,(unknown),Rajkumar Lalji Sahani,Karen A. Kirby,Haijuan Du,Atsuko Hachiya,Huanchun Zhang,Philip R. Tedbury,Jiashu Xie,Stefan G. Sarafianos,Zhengqiang Wang	21
4	Novel PF74-like small molecules targeting the HIV-1 capsid protein: Balance of potency and metabolic stability 2020 ·Acta Pharmaceutica Sinica B ·Lei Wang,Mary C. Casey,Sanjeev Kumar V. Vernekar,Rajkumar Lalji Sahani,Karen A. Kirby,Haijuan Du,Huanchun Zhang,Philip R. Tedbury,Jiashu Xie,Stefan G. Sarafianos,Zhengqiang Wang	25
5	Toward Structurally Novel and Metabolically Stable HIV-1 Capsid-Targeting Small Molecules 2020 ·Viruses ·Sanjeev Kumar V. Vernekar,Rajkumar Lalji Sahani,Mary C. Casey,Jayakanth Kankanala,Lei Wang,Karen A. Kirby,Haijuan Du,Huanchun Zhang,Philip R. Tedbury,Jiashu Xie,Stefan G. Sarafianos,Zhengqiang Wang	25
6	Mapping the Orthosteric Binding Site of the Human 5-HT₃ Receptor Using Photo-cross-linking Antagonists 2018 ·ACS Chemical Neuroscience ·Thomas R. Jack,Michele Leuenberger,Marc‐David Ruepp,Sanjeev Kumar V. Vernekar,Andrew J. Thompson,Sophie Braga-Lagache,Manfred Heller,Martin Lochner	6
7	Synthesis, biological evaluation and molecular modeling of 2-Hydroxyisoquinoline-1,3-dione analogues as inhibitors of HIV reverse transcriptase associated ribonuclease H and polymerase 2017 ·European Journal of Medicinal Chemistry ·Jing Tang,Sanjeev Kumar V. Vernekar,(unknown),(unknown),Andrew D. Huber,(unknown),Stefan G. Sarafianos,Michael A. Parniak,Zhengqiang Wang	23
8	Double-Winged 3-Hydroxypyrimidine-2,4-diones: Potent and Selective Inhibition against HIV-1 RNase H with Significant Antiviral Activity 2017 ·Journal of Medicinal Chemistry ·Sanjeev Kumar V. Vernekar,Jing Tang,Bulan Wu,Andrew D. Huber,Mary C. Casey,(unknown),Daniel J. Wilson,Jayakanth Kankanala,Karen A. Kirby,Michael A. Parniak,Stefan G. Sarafianos,Zhengqiang Wang	36
9	5′-Silylated 3′-1,2,3-triazolyl Thymidine Analogues as Inhibitors of West Nile Virus and Dengue Virus 2015 ·Journal of Medicinal Chemistry ·Sanjeev Kumar V. Vernekar,Li Qiu,Jing Zhang,Jayakanth Kankanala,Hongmin Li,Robert J. Geraghty,Zhengqiang Wang	75
10	Synthesis and antiviral evaluation of 4′-(1,2,3-triazol-1-yl)thymidines 2014 ·MedChemComm ·Sanjeev Kumar V. Vernekar,Li Qiu,(unknown),Robert J. Geraghty,Zhengqiang Wang	28
11	Design, Synthesis, Biochemical, and Antiviral Evaluations of C6 Benzyl and C6 Biarylmethyl Substituted 2-Hydroxylisoquinoline-1,3-diones: Dual Inhibition against HIV Reverse Transcriptase-Associated RNase H and Polymerase with Antiviral Activities 2014 ·Journal of Medicinal Chemistry ·Sanjeev Kumar V. Vernekar,Zheng Liu,Éva Nagy,(unknown),Karen A. Kirby,Daniel J. Wilson,Jayakanth Kankanala,Stefan G. Sarafianos,Michael A. Parniak,Zhengqiang Wang	123
12	Clicking 3′-Azidothymidine into Novel Potent Inhibitors of Human Immunodeficiency Virus 2013 ·Journal of Medicinal Chemistry ·Venkata Ramana Sirivolu,Sanjeev Kumar V. Vernekar,Tatiana V. Ilina,Nataliya S. Myshakina,Michael A. Parniak,Zhengqiang Wang	69
13	5-Arylidenethioxothiazolidinones as Inhibitors of Tyrosyl–DNA Phosphodiesterase I 2012 ·Journal of Medicinal Chemistry ·Venkata Ramana Sirivolu,Sanjeev Kumar V. Vernekar,Christophe Marchand,(unknown),Adel Chergui,Amèlie Renaud,Andrew G. Stephen,Feng Chen,Yuk Y. Sham,Yves Pommier,Zhengqiang Wang	55
14	High-affinity fluorescent ligands for the 5-HT3 receptor 2011 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Sanjeev Kumar V. Vernekar,Andrew J. Thompson,Joanne Hothersall,Christopher N. Connolly,Sarah C. R. Lummis,Martin Lochner	15
15	Toward Biophysical Probes for the 5-HT₃Receptor: Structure−Activity Relationship Study of Granisetron Derivatives 2010 ·Journal of Medicinal Chemistry ·Sanjeev Kumar V. Vernekar,(unknown),(unknown),Andrew J. Thompson,(unknown),Sarah C. R. Lummis,Martin Lochner	44
16	Syntheses of Branched Non‐1‐ynitols by Chemoselective Addition of (Trimethylsilyl)‐propargylmagnesium Bromide at the Anomeric Center of Side Chain Halogeno Functionalized Carbohydrates 2008 ·Journal of Carbohydrate Chemistry ·Sanjeev Kumar V. Vernekar,(unknown),Hartmut Redlich	1

About Sanjeev Kumar V. Vernekar

Sanjeev Kumar V. Vernekar is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 16 papers that have together received 577 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (10 papers) and Hepatitis C virus research (4 papers). The work is most often cited by research in Virology (181 citations), Infectious Diseases (246 citations) and Organic Chemistry (271 citations). Sanjeev Kumar V. Vernekar has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Zhengqiang Wang, Jayakanth Kankanala, Michael A. Parniak, Stefan G. Sarafianos, Karen A. Kirby, Venkata Ramana Sirivolu, Li Qiu, Robert J. Geraghty, Daniel J. Wilson and Zheng Liu. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact